The CAPTIM study [3] (multiple letters)

Lancet

Volumn 361, Issue 9358, 2003, Pages 700-701

  Hoye, Angela ^a   Dudek, Dariusz ^b   Kaluza, Grzegorz L ^b   Zmudka, Krzysztof ^b   Tracz, Wieslawa ^b   Dubiel, Jacek S ^b   Bonnefoy, Eric ^c   Lapostolle, Frédéric ^e   Leizorovicz, Alain ^d   Touboul, Paul ^c  

^a Thoraxcenter   (Netherlands)

^b Institute of Cardiology   (Poland)

^c LOUIS PRADEL HOSPITAL   (France)

^d Laennec Rockefeller University   (France)

^e Unité recherche enseignement qualité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT;

ANGIOPLASTY; BLEEDING; BLOOD CLOT LYSIS; BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FIBRINOLYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; LETTER; PATIENT TRANSPORT; PRIORITY JOURNAL; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; CORONARY ARTERY BYPASS GRAFT; EMERGENCY HEALTH SERVICE; METHODOLOGY; MORTALITY; NOTE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0037460702     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12577-9     Document Type: Letter

References (0)